Pulmozyme and Scopolamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pulmozyme (dornase alfa) and Scopolamine (scopolamine). Common drug interactions include death among females and pneumothorax among males.

The phase IV clinical study analyzes what interactions people have when they take Pulmozyme and Scopolamine. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Pulmozyme?

Pulmozyme has active ingredients of dornase alfa. It is often used in cystic fibrosis. eHealthMe is studying from 20,012 Pulmozyme users. Check the latest studies of Pulmozyme.

What is Scopolamine?

Scopolamine has active ingredients of scopolamine. eHealthMe is studying from 4,945 Scopolamine users. Check the latest studies of Scopolamine.

On Jul, 16, 2026

13 people who take Pulmozyme and Scopolamine together, and have interactions are studied.

Pulmozyme and Scopolamine drug interactions.

What are the common drug interactions of Pulmozyme and Scopolamine, by gender? *:

female:

Death
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Heart rate increased
Hypertension (high blood pressure)
Dyspnoea (difficult or laboured respiration)
Pulmonary oedema (fluid accumulation in the lungs)
Vomiting
Cardiac disorder
Loss of consciousness
Abdominal pain upper

male:

Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Respiratory disorder (respiratory disease)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Pain
Pneumonia
Respiratory distress (difficulty in breathing)
Respiratory failure (inadequate gas exchange by the respiratory system)
Thrombosis (formation of a blood clot inside a blood vessel)
Agitation (state of anxiety or nervous excitement)
Akathisia (a movement disorder characterized by a feeling of inner restlessness)

What are the common drug interactions of Pulmozyme and Scopolamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Agitation (state of anxiety or nervous excitement)
Akathisia (a movement disorder characterized by a feeling of inner restlessness)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Eye movement disorder
Mood altered (changes in mood)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Pneumonia
Respiratory distress (difficulty in breathing)

20-29:

Heart rate increased
Hospitalisation
Hypertension (high blood pressure)
Nausea (feeling of having an urge to vomit)
Vomiting
Weight decreased
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Abdominal pain upper
Drug ineffective
Dyspnoea (difficult or laboured respiration)

30-39:

Death
Heart rate increased
Hypertension (high blood pressure)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Pulmonary oedema (fluid accumulation in the lungs)
Respiratory failure (inadequate gas exchange by the respiratory system)

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Lung Disorder (lung disease): 4 people, 30.77%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 3 people, 23.08%
Scoliosis (a medical condition in which a person's spine is curved from side to side): 2 people, 15.38%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 2 people, 15.38%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 1 person, 7.69%
Pancreatic Insufficiency: 1 person, 7.69%
Pain: 1 person, 7.69%
Oedema (fluid collection in tissue): 1 person, 7.69%
Nausea (feeling of having an urge to vomit): 1 person, 7.69%
Infantile Spasms: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmozyme and Scopolamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously